Relationship between aortic stiffening and microvascular disease in brain and kidney: Cause and logic of therapy

Hypertension

Volumn 46, Issue 1, 2005, Pages 200-204

  O'Rourke, Michael F ^a,c   Safar, Michel E ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b HÔTEL DIEU   (France)

^c ST VINCENT'S CLINIC   (Australia)

Author keywords

Arterial pressure; Cerebrovascular disorders; Microcirculation; Pulse; Renal disease

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE;

AORTA DISEASE; ARTERY DILATATION; BLOOD VESSEL INJURY; BLOOD VESSEL SHUNT; BRAIN; BRAIN MICROCIRCULATION; CAROTID ARTERY; CLINICAL TRIAL; CONFERENCE PAPER; CORONARY ARTERY BLOOD FLOW; CORONARY BLOOD VESSEL; DISEASE ASSOCIATION; EXERCISE; HEART VENTRICLE SEPTUM DEFECT; HUMAN; IMPEDANCE; INTELLECTUAL IMPAIRMENT; KIDNEY; KIDNEY FAILURE; META ANALYSIS; MICROANGIOPATHY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULSE PRESSURE; PULSE WAVE; RENAL ARTERY; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE; VERTEBRAL ARTERY;

AORTA; BRAIN; COMPLIANCE; HUMANS; KIDNEY; MICROCIRCULATION; VASCULAR DISEASES;

EID: 21744459081     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000168052.00426.65     Document Type: Conference Paper

References (44)

1. Blacher J, Staessen JA, Girerd X, Gasowski J, Thijs L, Liu L, Wang JG, Fagard RH, Safar ME. Puise pressure, not mean pressure, determines cardiovascular risk in older hypertensive patients. Arch Intern Med. 2000;160:1085-1089.
2. Safar ME, Blacher J, Pannier B, Guerin AP, Marchais SJ, Guyonvarc'h PM, London GM. Central pulse pressure and mortality in end-stage renal disease. Hypertension. 2002;39:735-738.
3. Boutouyrie P, Tropeano A, Asmar R, Gautier I, Benetos A, Lacolley P, Laurent S. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients. Hypertension. 2002;39:10-15.
4. Weber T, Auer J, O'Rourke MF, Kvas E, Lassnig E, Berent R, Eber B. Arterial stiffness, wave reflection and the risk of coronary artery disease. Circulation. 2004;109:184-189.
5. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension. 2001;38:938-942.
6. Laurent P, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236-1241.
7. Meaume S, Benetos A, Henry OF, Rudnichi A, Safar ME. Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age. Arterioscler Thromb Vasc Biol. 2001;21:2046-2050.
8. Sutton-Tyrell K, Newman A, Simonsick EM, Havlik R, Pahor M, Lakatta E, Spurgeon H, Vaitkevicius P. for the Health ABC Investigators. Aortic stiffness is associated with visceral adiposity in older adults enrolled in the study of health, aging, and body composition. Hypertension. 2001;38:429-433.
9. Laurent P, Katsahian S, Fassot C, Tropeano AI, Gautier I, Laloux B, Boutouyrie P. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke. 2003;34:1203-1206.
10. Safar ME, London GM, Plante GE. Arterial stiffness and kidney function. Hypertension. 2004;43:163-168.
11. Schram MT, Kostense PJ, van Dijk RAJM, Dekker JM, Nijpels G, Bouter LM, Heine RJ, Stehouwer CDA. Diabetes, pulse pressure and cardiovascular mortality: the Hoorn study. J Hypertens. 2002;20:1743-1751.
12. Schram MR, Chaturvedi N, Fuller JH, Stehouwer CDA, and the EURODIAB Prospective Complications Study Group. Pulse pressure is associated with age and cardiovascular disease in type 1 diabetes: the Eurodiab Prospective Complications Study. J Hypertens. 2003;21:2035-2044.
13. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug therapy in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;365:3255-3264.
14. Hirata K, Vlachopoulos C, Adji A, O'Rourke MF. Benefit "beyond blood pressure lowering": beyond blood pressure or beyond the brachial artery (erratum J Hypertens. 2005;23:905-906). J Hypertens. 2005;23:551-556.
15. Stokes GS, Barin ES, Gilfillan KL. Effects of isosorbide mononitrate and All inhibition on pulse wave reflection in hypertension. Hypertension. 2003;41:298-301.
16. Morgan T, Lauri J, Bertram D, Anderson A. Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens. 2004;17:118-123.
17. Staessen JA, Wang JG, Birkenhager WH. Outcome beyond blood pressure control? Eur Heart J. 2003;24:504-514.
18. Staessen JA, Li Y, Thijs L, Wang JG. Changing concepts in the role of blood pressure reduction in cardiovascular prevention: an update including the 2003-2004 secondary prevention trials. In: Safar ME, O'Rourke MF, eds. Handbook of Hypertension: Arterial Stiffness and Wave Reflection. Paris: Elsevier; 2005. In press.
19. Williams B, Lacy P. Blood pressure and outcomes in clinical trials. J Hypertens. 2005;23:487-488.
20. Birkenhager WH, Forette F, Staessen JA. Dementia and antihypertensive treatment. Curr Opin Nephrol Hypertens. 2004;13:225-230.
21. O'Rourke MF. Vascular impedance in studies of arterial and cardiac function. Physiol Rev. 1982;62:570-623.
22. Pauca AL, Wallenhaupt SL, Kon ND, Tucker WY. Does radial artery pressure accurately reflect aortic pressure? Chest. 1992;102:1193-1198.
23. Pauca A, O'Rourke M, Kon N. Prospective evaluation of a method for estimating ascending aortic pressure form the radial artery pressure waveform. Hypertension. 2001;38:932-937.
24. O'Rourke MF. Steady and pulsatile energy losses in the systemic circulation under normal conditions and in simulated arterial disease. Cardiovasc Res. 1967;1:313-326.
25. Bergel DH, Milnor WR. Pulmonary vascular impedance in the dog. Circ Res. 1965;16:401-415.
26. Milnor WR, Conti CR, Lewis KB, O'Rourke MF. Pulmonary arterial pulse wave velocity and impedance in man. Circ Res. 1969;25:637-649.
27. Douglas JE, Greenfield JC. Epicardial coronary artery compliance in the dog. Circ Res. 1970;27:921-929.
28. Baumbach GL, Heistad DD. Regional, segmental, and temporal heterogeneity of cerebral vascular autoregulation. Ann Biomed Eng. 1985;13:303-310.
29. Faraci FM, Heistad DD. Regulation of large cerebral arteries and cerebral microvascular pressure. Circ Res. 1990;66:8-17.
30. Rizzoni D, Porteri E, Boari GE, De Ciuceis C, Sleiman I, Muiesan ML, Castellano M, Miclini M, Agabiti-Rosei E. Prognostic significance of small-artery structure in hypertension. Circulation. 2003;108:2230-2235.
31. Schofield I, Malik R, Izzard A, Austin C, Heagerty A. Vascular structure and functional changes in type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia. Circulation. 2002;106:3037-3043.
32. Verhave JC, Fesler P, du Cailar G, Ribstein J, Safar ME, Mimran A. Elevated pulse pressure is associated with low renal function in elderly patients with isolated systolic hypertension. Hypertension. 2005;45:586-591.
33. Avolio AP, Chen SG, Wang RP, Zhang CL, Li MF, O'Rourke MF. Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community. Circulation. 1983;868:50-58.
34. Nichols WW, O'Rourke MF. McDonald's Blood Flow in Arteries, 5th ed. London: Arnold; 2005.
35. Franklin SS, Gustin W, Wong ND, Larson MG, Weber MA, Kannel WB, Levy D. Hemodynamic patterns of age-related changes in blood pressure. Circulation. 1997;96:308-315.
36. Byrom FB. The pathogenesis of hypertensive encephalopathy and its relation to the malignant phase of hypertension: experimental evidence from the hypertensive rat. Lancet. 1954;II:201-211.
37. Byrom FB, Dodson LF. The causation of acute arterial necrosis in hypertensive disease. J Pathol Bacteriol. 1948;60:357-368.
38. Byrom F. The Hypertensive Vascular Crisis: An Experimental Study. London: Heinemann; 1969.
39. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation. 2001;103:987-992.
40. Yaginuma T, Avolio AP, O'Rourke MF, Nichols WW, Morgan JJ, Roy P, Baron D, Branson J, Feneley M. Effect of glyceryl trinitrate on peripheral arteries alters left ventricular hydraulic load in man. Cardiovasc Res. 1986;20:153-160.
41. London GM, Asmar RG, O'Rourke MF, Safar ME, on behalf of the REASON Project Investigators. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol. 2004;43:92-99.
42. Safar ME. Peripheral pulse pressure, large arteries, and microvessels. Hypertension. 2004;44:121-122.
43. Edwards JE. Functional pathology of the pulmonary vascular tree in congenital cardiac disease. Circulation. 1957;15:164-196.
44. Ledingham JM. The vascular fault in hypertension: Byrom's work revisited. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management. Raven: New York: 1995:37-53.